Please login to the form below

Not currently logged in
Email:
Password:

Bedrock Communications strengthens operations

Agency appoints six new team members

Bedrock

Medical communications group Bedrock Communications has bolstered its team with the addition of six new hires.

Joining the senior management team is Toby O’Brien, who formerly served as lead digital and creative services of Lucid Group.

He becomes Bedrock’s head of multichannel communications and will further enhance the agency’s strategic capabilities.

Alongside O’Brien, Meg Morgan becomes Bedrock Healthcare’s new strategic solutions director.

She also joins the senior management team and her new role will see her guide the company’s growth.

Strengthening the agency’s medical writing capability and therapy area expertise is new addition Emily Bell, who joins Bedrock as its principal medical writer and Sarah Cripps takes up the finance manager position.

Bolstering the accounts team are new hires Emma Garrard and Edward Jones, who take up account manager and account executive roles, respectively.

David Youds, chief executive officer of Bedrock, said: “These key strategic hires are instrumental to our growth.

“It’s an exciting and dynamic time in Bedrock’s evolution and im looking forward to each of our new team members bringing their passion, skills and enthusiasm to the Bedrock family.”

13th February 2018

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics